BeStock  
Stocks › Biotechnology › COGT

Cogent Biosciences COGT

US equityMarket cap rank #2102Biotechnology
$26.72 −$1.03 (-3.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.20 +1.82%
Open$27.26
Prev close$27.74
Day range$26.62 – $27.83
Volume2.13M
Market cap$4.65B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership120.7%+0.71 pts vs. prior quarter
Institutions holding394-4 vs. prior quarter
Insider trades (recent)36 buys / 14 sellsNet buying
Short interest10.04% of floatDays to cover 8.7 · as of 30 Oct 2026
Short-sale volume share15.2%5-day average of daily volume

Short-sale volume as % of daily volume

8%15%23%30%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$15.12M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$13.4MSuper−$1.7MBig+$1.6MMid+$4.4MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 38.7% of shares outstanding.

Largest holders

  • FMR15.43%
  • BlackRock9.90%
  • Vanguard Portfolio Management, LLC4.67%
  • State Street Global Advisors4.46%
  • Vanguard Capital Management, LLC4.28%
  • Janus Henderson Group plc3.81%
  • Fairmount Funds Management LLC3.18%
  • Commodore Capital LP3.10%

By investor type

  • Mutual Fund78.67%
  • Hedge Fund29.06%
  • VC/PE Fund7.99%
  • Public Company3.04%
  • Private Company0.56%
  • Individual/Insider0.55%
  • Government Pension Fund0.45%
  • Insurance Company0.35%

Reported short interest has fallen from 10.61% to 10.04% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Franklin Resources Mutual Fund 2026/Q3 +1,775,758 1.1%
FMR Mutual Fund 2026/Q3 +1,170,841 15.4%
Loomis, Sayles & Company L.P. Mutual Fund 2026/Q3 +1,115,760 0.6%
State Street Global Advisors Mutual Fund 2026/Q3 +805,230 4.5%
UBS Asset Management Mutual Fund 2026/Q3 +555,849 1.1%
Pictet Asset Management Limited Mutual Fund 2026/Q3 +449,261 1.6%
Polar Capital Holdings Plc Mutual Fund 2026/Q3 +3,232,905 1.9%
FMR Mutual Fund 2026/Q3 +2,558,484 14.8%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +1,439,912 2.7%
OrbiMed Advisors LLC VC/PE Fund 2026/Q3 +1,359,200 1.0%
BlackRock Mutual Fund 2026/Q3 +1,307,632 10.0%
State Street Global Advisors Mutual Fund 2026/Q3 +1,301,376 4.0%
Assenagon Asset Management S.A. Mutual Fund 2026/Q3 +1,146,106 0.8%
Woodline Partners LP Hedge Fund 2026/Q3 +1,093,605 1.5%
Deep Track Capital, LP VC/PE Fund 2026/Q3 +1,000,000 1.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
30 Sep 2026 Karen Jean Ferrante Independent Director Other Derivative Acquisition +759 $31.59 759
26 Aug 2026 Arlene Morris Independent Director Derivative Exercise and Sale -45,510 $37.54 –
30 Jun 2026 Karen Jean Ferrante Independent Director Other Derivative Acquisition +627 $38.48 627
8 Jun 2026 Arlene Morris Independent Director Other Derivative Acquisition +17,901 $31.98 17,901
8 Jun 2026 Matthew Ros Independent Director Other Derivative Acquisition +17,901 $31.98 17,901
8 Jun 2026 Todd Shegog Independent Director Other Derivative Acquisition +17,901 $31.98 17,901
8 Jun 2026 Karen Jean Ferrante Independent Director Other Derivative Acquisition +17,901 $31.98 17,901
8 Jun 2026 Christopher Cain Independent Director Other Derivative Acquisition +17,901 $31.98 17,901
8 Jun 2026 Peter Harwin Independent Chairperson Other Derivative Acquisition +17,901 $31.98 17,901
18 May 2026 Andrew Robbins Chief Executive Officer Other Acquisition +160,000 – 472,503
18 May 2026 Andrew Robbins Chief Executive Officer Other Disposition -160,000 – 472,503
31 Mar 2026 Karen Jean Ferrante Independent Director Other Derivative Acquisition +686 $35.24 686
30 Mar 2026 Fairmount Funds Management LLC Derivative Exercise and Sale -7,000,000 $34.66 5,503,418
21 Jan 2026 Fairmount Funds Management LLC Private Disposition -3,500,000 $36.40 5,503,418
31 Dec 2025 Karen Jean Ferrante Independent Director Other Derivative Acquisition +643 $34.74 643
25 Dec 2025 John Green Chief Financial Officer Open Market Disposition -77,000 $38.68 81,834
25 Dec 2025 Evan Kearns Chief Legal Officer Open Market Disposition -65,000 $38.70 69,398
25 Dec 2025 Jessica Sachs Chief Medical Officer Open Market Disposition -82,642 $38.70 83,938
25 Dec 2025 John Robinson Chief Scientific Officer Open Market Disposition -90,000 $38.74 90,002
16 Dec 2025 Andrew Robbins Chief Executive Officer Sale to Issuer -367,497 $39.45 472,503

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 17,416,118 10.0% 8.7
15 Oct 2026 19,661,566 11.3% 8.9
30 Sep 2026 19,462,718 11.2% 8.1
15 Sep 2026 18,126,492 10.4% 11.8
31 Aug 2026 18,747,531 10.8% 12.1
14 Aug 2026 18,411,111 10.6% 9.0

Discussion

No comments yet — be the first to weigh in on COGT.

Sign in to join the discussion.

Scroll to Top